---
title: "Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286968442.md"
description: "Insulet Corp. (PODD) shares rose 1.39% to $154.61 on Tuesday, despite a broader market decline, with the S&P 500 and Dow Jones falling 0.67% and 0.65%, respectively. The stock remains 56.43% below its 52-week high of $354.88. Compared to competitors, Insulet underperformed as Eli Lilly, DexCom, and Johnson & Johnson saw gains of 3.37%, 2.86%, and 0.47%."
datetime: "2026-05-19T21:15:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286968442.md)
  - [en](https://longbridge.com/en/news/286968442.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286968442.md)
---

# Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) rallied 1.39% to $154.61 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.

This was the stock's second consecutive day of gains.

Insulet Corp. closed 56.43% below its 52-week high of $354.88, which the company reached on November 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co. (LLY) rose 3.37% to $1,021.41, DexCom Inc. (DXCM) rose 2.86% to $66.95, and Johnson & Johnson (JNJ) rose 0.47% to $230.00.

Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-19-26 1715ET

### Related Stocks

- [PODD.US](https://longbridge.com/en/quote/PODD.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [A Look At Insulet (PODD) Valuation After Strong Q1 Results And Raised Revenue Guidance](https://longbridge.com/en/news/286451912.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)](https://longbridge.com/en/news/286443716.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)